These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 15888871)

  • 21. Heparin-induced thrombocytopenia, a prothrombotic disease.
    Levy JH; Hursting MJ
    Hematol Oncol Clin North Am; 2007 Feb; 21(1):65-88. PubMed ID: 17258119
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Non-injection-site necrotic skin lesions complicating postoperative heparin thromboprophylaxis.
    Tassava T; Warkentin TE
    Am J Hematol; 2015 Aug; 90(8):747-50. PubMed ID: 25808584
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Heparin-induced non-necrotizing skin lesions: rarely associated with heparin-induced thrombocytopenia.
    Schindewolf M; Kroll H; Ackermann H; Garbaraviciene J; Kaufmann R; Boehncke WH; Ludwig RJ; Lindhoff-Last E
    J Thromb Haemost; 2010 Jul; 8(7):1486-91. PubMed ID: 20128858
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the patient population on the risk for heparin-induced thrombocytopenia.
    Warkentin TE; Sheppard JA; Horsewood P; Simpson PJ; Moore JC; Kelton JG
    Blood; 2000 Sep; 96(5):1703-8. PubMed ID: 10961867
    [TBL] [Abstract][Full Text] [Related]  

  • 25. An overview of the heparin-induced thrombocytopenia syndrome.
    Warkentin TE
    Semin Thromb Hemost; 2004 Jun; 30(3):273-83. PubMed ID: 15282649
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Incidence and clinical significance of anti-PF4/heparin antibodies of the IgG, IgM, and IgA class in 755 consecutive patient samples referred for diagnostic testing for heparin-induced thrombocytopenia.
    Juhl D; Eichler P; Lubenow N; Strobel U; Wessel A; Greinacher A
    Eur J Haematol; 2006 May; 76(5):420-6. PubMed ID: 16466367
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of circuit and AV fistula clotting and detection of anti-PF4/heparin complex antibodies in hemodialysis patients suspected of having heparin-induced thrombocytopenia.
    Matsuo T; Wanaka K; Walenga JM
    Clin Appl Thromb Hemost; 2013; 19(1):73-8. PubMed ID: 22345486
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Heparin-induced thrombocytopenia.
    Greinacher A; Althaus K; Krauel K; Selleng S
    Hamostaseologie; 2010 Jan; 30(1):17-8, 20-8. PubMed ID: 20162249
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Heparin-induced anaphylactic and anaphylactoid reactions: two distinct but overlapping syndromes.
    Warkentin TE; Greinacher A
    Expert Opin Drug Saf; 2009 Mar; 8(2):129-44. PubMed ID: 19309242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. How frequently is venous thromboembolism in heparin-treated patients associated with heparin-induced thrombocytopenia?
    Levine RL; McCollum D; Hursting MJ
    Chest; 2006 Sep; 130(3):681-7. PubMed ID: 16963663
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Heparin-induced thrombocytopenia.
    Chong BH; Chong JJ
    Expert Rev Cardiovasc Ther; 2004 Jul; 2(4):547-59. PubMed ID: 15225114
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fondaparinux for the treatment of patients with acute heparin-induced thrombocytopenia.
    Lobo B; Finch C; Howard A; Minhas S
    Thromb Haemost; 2008 Jan; 99(1):208-14. PubMed ID: 18217156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immune heparin-induced thrombocytopenia can occur in patients receiving clopidogrel and aspirin.
    Selleng K; Selleng S; Raschke R; Schmidt CO; Rosenblood GS; Greinacher A; Warkentin TE
    Am J Hematol; 2005 Mar; 78(3):188-92. PubMed ID: 15726594
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Heparin-induced thrombocytopenia after liver transplantation.
    Kaneko J; Sugawara Y; Tamura S; Togashi J; Matsui Y; Makuuchi M
    Transplant Proc; 2008 Jun; 40(5):1518-21. PubMed ID: 18589141
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Heparin-induced thrombocytopenia type II in a surgical intensive care unit.
    Sakr Y; Haetscher F; Gonsalves MD; Hoffman M; Theis B; Barz D; Reinhart K; Kortgen A
    J Crit Care; 2012 Jun; 27(3):232-41. PubMed ID: 21855286
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Incidence of heparin-induced thrombocytopenia type II and postoperative recovery of platelet count in liver graft recipients: a retrospective cohort analysis.
    Bachmann R; Bachmann J; Lange J; Nadalin S; Königsrainer A; Ladurner R
    J Surg Res; 2014 Jan; 186(1):429-35. PubMed ID: 24100055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Heparin-induced thrombocytopenia.
    Fabris F; Luzzatto G; Stefani PM; Girolami B; Cella G; Girolami A
    Haematologica; 2000 Jan; 85(1):72-81. PubMed ID: 10629596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Warfarin-induced skin necrosis and venous limb gangrene in the setting of heparin-induced thrombocytopenia.
    Srinivasan AF; Rice L; Bartholomew JR; Rangaswamy C; La Perna L; Thompson JE; Murphy S; Baker KR
    Arch Intern Med; 2004 Jan; 164(1):66-70. PubMed ID: 14718324
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effectiveness of a new immunoassay for the diagnosis of heparin-induced thrombocytopenia and improved specificity when detecting IgG antibodies.
    Pouplard C; Leroux D; Regina S; Rollin J; Gruel Y
    Thromb Haemost; 2010 Jan; 103(1):145-50. PubMed ID: 20062918
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Molecular mechanism underlines heparin-induced thrombocytopenia and thrombosis.
    Qian Y; Pan J; Zhou X; Weiser P; Lu H; Zhang L
    Prog Mol Biol Transl Sci; 2010; 93():395-421. PubMed ID: 20807654
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.